KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Other Non-Current Liabilities: 2014-2025

Historic Other Non-Current Liabilities for Exact Sciences (EXAS) over the last 11 years, with Sep 2025 value amounting to $324.8 million.

  • Exact Sciences' Other Non-Current Liabilities fell 2.23% to $324.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $324.8 million, marking a year-over-year decrease of 2.23%. This contributed to the annual value of $315.5 million for FY2024, which is 6.10% down from last year.
  • According to the latest figures from Q3 2025, Exact Sciences' Other Non-Current Liabilities is $324.8 million, which was up 2.82% from $315.9 million recorded in Q2 2025.
  • Exact Sciences' Other Non-Current Liabilities' 5-year high stood at $439.2 million during Q2 2021, with a 5-year trough of $315.5 million in Q4 2024.
  • In the last 3 years, Exact Sciences' Other Non-Current Liabilities had a median value of $329.4 million in 2024 and averaged $328.9 million.
  • As far as peak fluctuations go, Exact Sciences' Other Non-Current Liabilities spiked by 776.57% in 2021, and later fell by 18.69% in 2022.
  • Over the past 5 years, Exact Sciences' Other Non-Current Liabilities (Quarterly) stood at $417.8 million in 2021, then fell by 15.64% to $352.5 million in 2022, then fell by 4.67% to $336.0 million in 2023, then decreased by 6.10% to $315.5 million in 2024, then fell by 2.23% to $324.8 million in 2025.
  • Its Other Non-Current Liabilities stands at $324.8 million for Q3 2025, versus $315.9 million for Q2 2025 and $320.2 million for Q1 2025.